Elokdah; Hassan Mahmoud

Patent Applications and Registrations

Patent applications and USPTO patent grants for Elokdah; Hassan Mahmoud.The latest application filed is for "sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands".

Company Profile

0.26.35

Elokdah; Hassan Mahmoud - North Wales PA
Elokdah; Hassan Mahmoud - Yardley PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,790,751 - Elokdah , et al. September 7, 2	2010-09-07
Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,723,329 - Elokdah , et al. May 25, 2	2010-05-25
Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) Grant 7,674,818 - Jennings , et al. March 9, 2	2010-03-09
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) Grant 7,629,377 - Crandall , et al. December 8, 2	2009-12-08
Biphenyloxy-acids Grant 7,534,894 - Commons , et al. May 19, 2	2009-05-19
Sulfonyl-3-heterocyclylindazole Derivatives As 5-hydroxytryptamine-6 Ligands App 20090105303 - Liu; Kevin ; et al.	2009-04-23
Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,501,421 - Liu , et al. March 10, 2	2009-03-10
Substituted Heteroaryl Benzofuran Acids App 20090054484 - ELOKDAH; Hassan Mahmoud ; et al.	2009-02-26
Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,482,461 - Liu , et al. January 27, 2	2009-01-27
1-heterocyclylalkyl-3-sulfonylazaindole Or -azaindazole Derivatives As 5-hydroxytryptamine-6 Ligands App 20080306106 - Bernotas; Ronald Charles ; et al.	2008-12-11
Substituted Aryl Oximes App 20080293790 - Havran; Lisa Marie ; et al.	2008-11-27
DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS App 20080280894 - Greenfield; Alexander Alexei ; et al.	2008-11-13
SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS App 20080280893 - Elokdah; Hassan Mahmoud ; et al.	2008-11-13
Substituted heteroaryl benzofuran acids Grant 7,446,201 - Elokdah , et al. November 4, 2	2008-11-04
Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands and use thereof in the treatment of attention deficit disorders Grant 7,429,582 - Greenfield , et al. September 30, 2	2008-09-30
Substituted Indole Acid Derivatives As Inhibitors Of Plasminogen Activator Inhibitor-1 (pai-1) App 20080214647 - Elokdah; Hassan Mahmoud ; et al.	2008-09-04
Substituted aryloximes Grant 7,420,083 - Havran , et al. September 2, 2	2008-09-02
Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,414,051 - Elokdah , et al. August 19, 2	2008-08-19
1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,411,064 - Bernotas , et al. August 12, 2	2008-08-12
Substituted Naphthyl Indole Derivatives As Inhibitors Of Plasminogen Activator Inhibitor Type-1 (pai-1) App 20080182883 - Crandall; David LeRoy ; et al.	2008-07-31
Substituted oxadiazolidinediones Grant 7,351,726 - Elokdah , et al. April 1, 2	2008-04-01
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) Grant 7,351,730 - Mayer , et al. April 1, 2	2008-04-01
Substituted indole oximes Grant 7,342,039 - Havran , et al. March 11, 2	2008-03-11
1-Sulfonylindazolylamine and - amide derivatives as 5-hydroxytryptamine-6 ligands App 20070281922 - Liu; Kevin ; et al.	2007-12-06
Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands App 20070281945 - Liu; Kevin ; et al.	2007-12-06
Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20070259922 - Jennings; Lee Dalton ; et al.	2007-11-08
Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) Grant 7,291,639 - Elokdah November 6, 2	2007-11-06
Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands App 20070244105 - Greenfield; Alexander Alexei ; et al.	2007-10-18
Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands App 20070244106 - Elokdah; Hassan Mahmoud ; et al.	2007-10-18
Dihydro[1,4]dioxino[2,3-e]indazole derivatives as 5-hydroxytryptamine-6 ligands App 20070244179 - Greenfield; Alexander Alexei ; et al.	2007-10-18
Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands App 20070238724 - Liu; Kevin ; et al.	2007-10-11
Aryl, aryloxy, and aklyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) Grant 7,259,182 - Jennings , et al. August 21, 2	2007-08-21
Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands App 20070054896 - Elokdah; Hassan Mahmoud ; et al.	2007-03-08
Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands App 20070037802 - Elokdah; Hassan Mahmoud ; et al.	2007-02-15
Substituted naphthyl benzothiophene acids Grant 7,163,954 - Elokdah , et al. January 16, 2	2007-01-16
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor (PAI-1) Grant 7,160,918 - Elokdah , et al. January 9, 2	2007-01-09
Substituted dihydropyrano indole-3,4-dione derivatives as inhibitiors of plasminogen activator inhibitor-1 (PAI-1) Grant 7,101,903 - Elokdah , et al. September 5, 2	2006-09-05
Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20060167059 - Elokdah; Hassan Mahmoud ; et al.	2006-07-27
Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) Grant 7,074,817 - Elokdah , et al. July 11, 2	2006-07-11
1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands App 20060142330 - Bernotas; Ronald Charles ; et al.	2006-06-29
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor (PAI-1) App 20060122254 - Elokdah; Hassan Mahmoud ; et al.	2006-06-08
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) Grant 7,056,943 - Elokdah , et al. June 6, 2	2006-06-06
1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands Grant 7,057,039 - Bernotas , et al. June 6, 2	2006-06-06
Biphenyloxy-acids App 20060020003 - Commons; Thomas Joseph ; et al.	2006-01-26
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) App 20060014725 - Mayer; Scott Christian ; et al.	2006-01-19
Substituted benzofuran oximes App 20050215626 - Havran, Lisa Marie ; et al.	2005-09-29
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) Grant 6,939,886 - Mayer , et al. September 6, 2	2005-09-06
Substituted heteroaryl benzofuran acids App 20050119296 - Elokdah, Hassan Mahmoud ; et al.	2005-06-02
Substituted aryloximes App 20050119326 - Havran, Lisa Marie ; et al.	2005-06-02
Substituted aryloximes App 20050070584 - Havran, Lisa Marie ; et al.	2005-03-31
Substituted naphthyl benzothiophene acids App 20050070587 - Elokdah, Hassan Mahmoud ; et al.	2005-03-31
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) App 20040266733 - Mayer, Scott Christian ; et al.	2004-12-30
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) Grant 6,800,654 - Mayer , et al. October 5, 2	2004-10-05
Aryl, aryloxy, and alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20040138283 - Jennings, Lee Dalton ; et al.	2004-07-15
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20040116504 - Elokdah, Hassan Mahmoud ; et al.	2004-06-17
1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands App 20040023970 - Bernotas, Ronald Charles ; et al.	2004-02-05
Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) Grant 6,599,925 - Elokdah , et al. July 29, 2	2003-07-29
Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20030125371 - Elokdah, Hassan Mahmoud ; et al.	2003-07-03
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) App 20030032626 - Mayer, Scott Christian ; et al.	2003-02-13
Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20030018067 - Elokdah, Hassan Mahmoud ; et al.	2003-01-23
Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) App 20030013732 - Elokdah, Hassan Mahmoud	2003-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.